The total number of U.S. pharmaceutical sales that went to market through pharmaceutical distributors increased to nearly 95.7 percent in 2016 (nearly two percentage points over the previous year) according to a new report published by the HDA Research Foundation. The Foundation released this new statistic in its 88th Edition HDA Factbook: The Facts, Figures and Trends in Healthcare (2017-2018).
The Healthcare Distribution Alliance (HDA) today announces an expansion of its membership offerings and expertise by adding the Pharmaceutical Cargo Security Coalition (PCSC) to its organization. This new service offering will go into full effect as of January 1, 2018. PCSC’s founder, Chuck Forsaith, will continue to lead the coalition as Senior Director with HDA.
Following the new report released by the President’s Commission on Combating Drug Addiction and the Opioid Crisis, Healthcare Distribution Alliance (HDA) President and CEO John M. Gray released the following statement.
Following President Trump’s announcement on the response to the opioid epidemic, Healthcare Distribution Alliance (HDA) President and CEO John M. Gray issued the following statement.
The recent investigation by The Washington Post presented a misleading picture about the role of healthcare distributors in the pharmaceutical supply chain and the regulation of controlled substances and opioids in the market. Here are the facts and the information that The Post won’t share about the industry’s role and our members’ efforts to prevent diversion of controlled substances across the healthcare system.
John Parker
(703) 885-0216
Farah Simonett
(703) 885-0269
